Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Don2018on Nov 05, 2019 2:48pm

142 Views

Post# 30311821

RE:RE:Updates to watch out for - Sirona’s top 10

MirrorWorldMan wrote: In the next 6 months, Maybe 1 & 4 & (11) [Another Placement] and (12) [Futher Delays]. The Stock price is not likely to reach your anticipated levels given 'stuck in the mud' price inelasticy to recent PR's. Given management history, I speculate the rest of your premonitions may will likely occur within the next 6 years, not 6 months. I would love to be wrong.

Once again, idiots like you fail to understand what is holding down the share price.

Hint, it has nothing to do with anything your peabrain can comprehend.

And there won't be another PP unless another strategic investor wants a stake.

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property